A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Abroad (travel likely)RecruitingPHASE2

Conditions

Neuroblastoma · Sarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Children's Hospital of Alabama/UAB, Birmingham, Alabama, United States
Contact: Study coordinator (Elizabeth Alva, MD, MSPH) · ealva@uabmc.edu · 205-638-9285
Children's Hospital of Colorado, Aurora, Colorado, United States
Contact: Study coordinator (Emily Blauel, MD) · emily.blauel@childrenscolorado.org · 720-777-6740
Children's National Medical Center, Washington D.C., District of Columbia, United States
Contact: Study coordinator (Kim AeRang, MD) · AeKim@childrensnational.org · 202-476-2800
Children's Hospital at Montefiore, The Bronx, New York, United States
Contact: Study coordinator (Alice Lee, MD) · alee5@montefiore.org
Nationwide Children's Hospital, Columbus, Ohio, United States
Contact: Study coordinator (Kelly Hadinger) · kelly.hadinger@nationwidechildrens.org · 6143551231
Contact: Principal Investigator (Nilay Shah, MD)
Primary Children's Hospital, Salt Lake City, Utah, United States
Contact: Study coordinator (Matthew Dietz, MD) · matthew.dietz@hsc.utah.edu · 801-662-4700

Study leads

Nilay Shah, MD
Principal Investigator
Nationwide Children's Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

Atypical Teratoid/Rhabdoid Tumor · Embryonal Tumor With Multilayered Rosettes · Ewing Sarcoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Birmingham, United States · Little Rock, United States

Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

Neuroblastoma · Rhabdomyosarcoma · Synovial Sarcoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Gainesville, United States

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Colorectal Carcinoma · Endometrial Carcinoma · Melanoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Birmingham, United States · Los Angeles, United States

Agnostic Therapy in Rare Solid Tumors

Urachal Cancer · Parathyroid Carcinoma · Fibrolamellar Carcinoma

Abroad (travel likely)RecruitingPHASE2

Fortaleza, Brazil · Salvador, Brazil